Effect of inulin in the treatment of irritable bowel syndrome with constipation (Review)
At present, irritable bowel syndrome (IBS) is a common medical problem all over the world that implies considerable social burden and high costs. Considering the different pathophysiological pathways, unitary management for IBS is not possible. Of the therapeutic approaches that have been proposed s...
Gespeichert in:
| Veröffentlicht in: | Experimental and therapeutic medicine 2020-12, Vol.20 (6), p.1-1 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1 |
|---|---|
| container_issue | 6 |
| container_start_page | 1 |
| container_title | Experimental and therapeutic medicine |
| container_volume | 20 |
| creator | Barboi, Oana-bogdana Ciortescu, Irina Chirila, Ioan Anton, Carmen Drug, Vasile |
| description | At present, irritable bowel syndrome (IBS) is a common medical problem all over the world that implies considerable social burden and high costs. Considering the different pathophysiological pathways, unitary management for IBS is not possible. Of the therapeutic approaches that have been proposed so far, only a few have been demonstrated to have beneficial effects in IBS patients. The implication of gut microbiota in IBS is obvious, similarly to the therapeutic effect of pro-/prebiotics, which is reflected by the latest publications. The intake of inulin seems to regulate the bowel peristalsis and colonic transit, the consistency and frequency of the stools, as it changes the composition of gut microbiota. The beneficial effect of inulin in patients with IBS-constipation form (IBS-C) is obvious, but still, more randomized controlled clinical trials involving large samples of patients are needed in order to provide more evidence. |
| doi_str_mv | 10.3892/etm.2020.9315 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7579772</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A646884949</galeid><sourcerecordid>A646884949</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-365025ddf5150ce7fe8c9b30c610bc3661e06733ee06e9d87f128e74ff0250a3</originalsourceid><addsrcrecordid>eNptks9LHDEUx0OpVFGPvQ_0Yg-zTSY_51IQsa0gFMSDt5DJvLiRmWSbZFz8782yS4vF5PBC3ud98174IvSZ4BVVffcNyrzqcIdXPSX8Azohsu9aggn_eDjjXpFjdJ7zE66LC6IU_4SOKa0Qk_wEPVw7B7Y00TU-LJMPNTRlDU1JYMoMYZ9KyRczTNAMcQtTk1_CmOIMzdaXdWNjyMVvTPExNBd38Oxh-_UMHTkzZTg_xFN0_-P6_upXe_v7583V5W1r6wSlpYLjjo-j44RjC9KBsv1AsRUED5YKQQALSSnUAP2opCOdAsmcq2XY0FP0fS-7WYYZRlsbTmbSm-Rnk150NF6_zQS_1o_xWUsueym7KnBxEEjxzwK56NlnC9NkAsQl645xxkhtU1b0y3_oU1xSqNNVSlAsCOXsH_VoJtA-uFjftTtRfSmYUIr1rK_U6h2q7hFmXz8UnK_3bwrafYFNMecE7u-MBOudGXQ1g96ZQe_MQF8BlN2k0A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2463061354</pqid></control><display><type>article</type><title>Effect of inulin in the treatment of irritable bowel syndrome with constipation (Review)</title><source>PubMed Central</source><creator>Barboi, Oana-bogdana ; Ciortescu, Irina ; Chirila, Ioan ; Anton, Carmen ; Drug, Vasile</creator><creatorcontrib>Barboi, Oana-bogdana ; Ciortescu, Irina ; Chirila, Ioan ; Anton, Carmen ; Drug, Vasile</creatorcontrib><description>At present, irritable bowel syndrome (IBS) is a common medical problem all over the world that implies considerable social burden and high costs. Considering the different pathophysiological pathways, unitary management for IBS is not possible. Of the therapeutic approaches that have been proposed so far, only a few have been demonstrated to have beneficial effects in IBS patients. The implication of gut microbiota in IBS is obvious, similarly to the therapeutic effect of pro-/prebiotics, which is reflected by the latest publications. The intake of inulin seems to regulate the bowel peristalsis and colonic transit, the consistency and frequency of the stools, as it changes the composition of gut microbiota. The beneficial effect of inulin in patients with IBS-constipation form (IBS-C) is obvious, but still, more randomized controlled clinical trials involving large samples of patients are needed in order to provide more evidence.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2020.9315</identifier><identifier>PMID: 33101475</identifier><language>eng</language><publisher>Athens: Spandidos Publications</publisher><subject>Bacteria ; Care and treatment ; Chronic illnesses ; Clinical trials ; Colon ; Constipation ; Dietary fiber ; FDA approval ; Food ; Inulin ; Irritable bowel syndrome ; Microbiota ; Prebiotics ; Quality of life ; Review ; Yogurt</subject><ispartof>Experimental and therapeutic medicine, 2020-12, Vol.20 (6), p.1-1</ispartof><rights>COPYRIGHT 2020 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2020</rights><rights>Copyright © 2020, Spandidos Publications 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-365025ddf5150ce7fe8c9b30c610bc3661e06733ee06e9d87f128e74ff0250a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579772/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579772/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids></links><search><creatorcontrib>Barboi, Oana-bogdana</creatorcontrib><creatorcontrib>Ciortescu, Irina</creatorcontrib><creatorcontrib>Chirila, Ioan</creatorcontrib><creatorcontrib>Anton, Carmen</creatorcontrib><creatorcontrib>Drug, Vasile</creatorcontrib><title>Effect of inulin in the treatment of irritable bowel syndrome with constipation (Review)</title><title>Experimental and therapeutic medicine</title><description>At present, irritable bowel syndrome (IBS) is a common medical problem all over the world that implies considerable social burden and high costs. Considering the different pathophysiological pathways, unitary management for IBS is not possible. Of the therapeutic approaches that have been proposed so far, only a few have been demonstrated to have beneficial effects in IBS patients. The implication of gut microbiota in IBS is obvious, similarly to the therapeutic effect of pro-/prebiotics, which is reflected by the latest publications. The intake of inulin seems to regulate the bowel peristalsis and colonic transit, the consistency and frequency of the stools, as it changes the composition of gut microbiota. The beneficial effect of inulin in patients with IBS-constipation form (IBS-C) is obvious, but still, more randomized controlled clinical trials involving large samples of patients are needed in order to provide more evidence.</description><subject>Bacteria</subject><subject>Care and treatment</subject><subject>Chronic illnesses</subject><subject>Clinical trials</subject><subject>Colon</subject><subject>Constipation</subject><subject>Dietary fiber</subject><subject>FDA approval</subject><subject>Food</subject><subject>Inulin</subject><subject>Irritable bowel syndrome</subject><subject>Microbiota</subject><subject>Prebiotics</subject><subject>Quality of life</subject><subject>Review</subject><subject>Yogurt</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptks9LHDEUx0OpVFGPvQ_0Yg-zTSY_51IQsa0gFMSDt5DJvLiRmWSbZFz8782yS4vF5PBC3ud98174IvSZ4BVVffcNyrzqcIdXPSX8Azohsu9aggn_eDjjXpFjdJ7zE66LC6IU_4SOKa0Qk_wEPVw7B7Y00TU-LJMPNTRlDU1JYMoMYZ9KyRczTNAMcQtTk1_CmOIMzdaXdWNjyMVvTPExNBd38Oxh-_UMHTkzZTg_xFN0_-P6_upXe_v7583V5W1r6wSlpYLjjo-j44RjC9KBsv1AsRUED5YKQQALSSnUAP2opCOdAsmcq2XY0FP0fS-7WYYZRlsbTmbSm-Rnk150NF6_zQS_1o_xWUsueym7KnBxEEjxzwK56NlnC9NkAsQl645xxkhtU1b0y3_oU1xSqNNVSlAsCOXsH_VoJtA-uFjftTtRfSmYUIr1rK_U6h2q7hFmXz8UnK_3bwrafYFNMecE7u-MBOudGXQ1g96ZQe_MQF8BlN2k0A</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Barboi, Oana-bogdana</creator><creator>Ciortescu, Irina</creator><creator>Chirila, Ioan</creator><creator>Anton, Carmen</creator><creator>Drug, Vasile</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201201</creationdate><title>Effect of inulin in the treatment of irritable bowel syndrome with constipation (Review)</title><author>Barboi, Oana-bogdana ; Ciortescu, Irina ; Chirila, Ioan ; Anton, Carmen ; Drug, Vasile</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-365025ddf5150ce7fe8c9b30c610bc3661e06733ee06e9d87f128e74ff0250a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Bacteria</topic><topic>Care and treatment</topic><topic>Chronic illnesses</topic><topic>Clinical trials</topic><topic>Colon</topic><topic>Constipation</topic><topic>Dietary fiber</topic><topic>FDA approval</topic><topic>Food</topic><topic>Inulin</topic><topic>Irritable bowel syndrome</topic><topic>Microbiota</topic><topic>Prebiotics</topic><topic>Quality of life</topic><topic>Review</topic><topic>Yogurt</topic><toplevel>online_resources</toplevel><creatorcontrib>Barboi, Oana-bogdana</creatorcontrib><creatorcontrib>Ciortescu, Irina</creatorcontrib><creatorcontrib>Chirila, Ioan</creatorcontrib><creatorcontrib>Anton, Carmen</creatorcontrib><creatorcontrib>Drug, Vasile</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barboi, Oana-bogdana</au><au>Ciortescu, Irina</au><au>Chirila, Ioan</au><au>Anton, Carmen</au><au>Drug, Vasile</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of inulin in the treatment of irritable bowel syndrome with constipation (Review)</atitle><jtitle>Experimental and therapeutic medicine</jtitle><date>2020-12-01</date><risdate>2020</risdate><volume>20</volume><issue>6</issue><spage>1</spage><epage>1</epage><pages>1-1</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>At present, irritable bowel syndrome (IBS) is a common medical problem all over the world that implies considerable social burden and high costs. Considering the different pathophysiological pathways, unitary management for IBS is not possible. Of the therapeutic approaches that have been proposed so far, only a few have been demonstrated to have beneficial effects in IBS patients. The implication of gut microbiota in IBS is obvious, similarly to the therapeutic effect of pro-/prebiotics, which is reflected by the latest publications. The intake of inulin seems to regulate the bowel peristalsis and colonic transit, the consistency and frequency of the stools, as it changes the composition of gut microbiota. The beneficial effect of inulin in patients with IBS-constipation form (IBS-C) is obvious, but still, more randomized controlled clinical trials involving large samples of patients are needed in order to provide more evidence.</abstract><cop>Athens</cop><pub>Spandidos Publications</pub><pmid>33101475</pmid><doi>10.3892/etm.2020.9315</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1792-0981 |
| ispartof | Experimental and therapeutic medicine, 2020-12, Vol.20 (6), p.1-1 |
| issn | 1792-0981 1792-1015 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7579772 |
| source | PubMed Central |
| subjects | Bacteria Care and treatment Chronic illnesses Clinical trials Colon Constipation Dietary fiber FDA approval Food Inulin Irritable bowel syndrome Microbiota Prebiotics Quality of life Review Yogurt |
| title | Effect of inulin in the treatment of irritable bowel syndrome with constipation (Review) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T11%3A16%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20inulin%20in%20the%20treatment%20of%20irritable%20bowel%20syndrome%20with%20constipation%20(Review)&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Barboi,%20Oana-bogdana&rft.date=2020-12-01&rft.volume=20&rft.issue=6&rft.spage=1&rft.epage=1&rft.pages=1-1&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2020.9315&rft_dat=%3Cgale_pubme%3EA646884949%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2463061354&rft_id=info:pmid/33101475&rft_galeid=A646884949&rfr_iscdi=true |